686 results on '"Krengli M"'
Search Results
2. Teaching Cases in Nuclear Oncology: Uterine Cancers
- Author
-
Lorenzoni, Alice, Alessi, Alessandra, Crippa, Flavio, Reyneke, F., Sathekge, M., Neriman, D., Connelly, J. P., Al-Riyami, K., Deantonio, L., Orsini, Federica, Matheoud, R., Krengli, M., Sacchetti, G. M., Volterrani, Duccio, editor, Erba, Paola A., editor, Strauss, H. William, editor, Mariani, Giuliano, editor, and Larson, Steven M., editor
- Published
- 2022
- Full Text
- View/download PDF
3. Local primary tumor and metastasis treatment in patients with newly diagnosed oligometastatic prostate cancer: a prospective multicenter registry (OLIGOS)
- Author
-
Porreca, A., primary, Lista, G., additional, Di Gianfrancesco, L., additional, Sepulcri, M., additional, Corsi, P., additional, Miglioranza, E., additional, Amodeo, A., additional, De Marchi, D., additional, Vitelli, F.D., additional, and Krengli, M., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
- Author
-
Pisani, C., Vigna, L., Mastroleo, F., Loi, G., Amisano, V., Masini, L., Deantonio, L., Aluffi Valletti, P., Sacchetti, G., and Krengli, M.
- Published
- 2021
- Full Text
- View/download PDF
5. OC-0593 Process Mining: a new approach for improving patients' care path in radiation oncology department
- Author
-
Mastroleo, F., primary, Pepa, M., additional, Gatta, R., additional, Capobianco, G., additional, Dima, L., additional, Volpe, S., additional, Zaffaroni, M., additional, Sarra Fiore, M., additional, Rondi, E., additional, Ferrari, A.M., additional, Krengli, M., additional, Marvaso, G., additional, and Jereczek-Fossa, B.A., additional
- Published
- 2023
- Full Text
- View/download PDF
6. PO-1401 Elderly Anal Cancer Patients Treated With Intensity-Modulated Radiation Therapy: A Multicenter Study
- Author
-
Caravatta, L., primary, Mantello, G., additional, Valvo, F., additional, Franco, P., additional, Gasparini, L., additional, Di Guglielmo, F.C., additional, Slim, N., additional, Manfrida, S., additional, Gambacorta, M.A., additional, De Felice, F., additional, Gerardi, M.A., additional, Vagge, S., additional, Krengli, M., additional, Palazzari, E., additional, Osti, M.F., additional, Gonnelli, A., additional, Catalano, G., additional, Pittoni, P., additional, Ivaldi, G.B., additional, Galardi, A., additional, Lupattelli, M., additional, Rosetto, M.E., additional, Niespolo, R.M., additional, Guido, A., additional, Durante, O., additional, Macchia, G., additional, Munoz, F., additional, Khouzai, B.E., additional, Lucido, M.R., additional, D'Angelillo, R.M., additional, Porreca, A., additional, Di Nicola, M., additional, and Genovesi, D., additional
- Published
- 2023
- Full Text
- View/download PDF
7. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database
- Author
-
Salas, S., Resseguier, N., Blay, J.Y., Le Cesne, A., Italiano, A., Chevreau, C., Rosset, P., Isambert, N., Soulie, P., Cupissol, D., Delcambre, C., Bay, J.O., Dubray-Longeras, P., Krengli, M., De Bari, B., Villa, S., Kaanders, J.H.A.M., Torrente, S., Pasquier, D., Thariat, J.O., Myroslav, L., Sole, C.V., Dincbas, H.F., Habboush, J.Y., Zilli, T., Dragan, T., Khanfir, K., Ugurluer, G., Cena, T., Duffaud, F., Penel, N., Bertucci, F., Ranchere-Vince, D., Terrier, P., Bonvalot, S., Macagno, N., Lemoine, C., Lae, M., Coindre, J.M., and Bouvier, C.
- Published
- 2017
- Full Text
- View/download PDF
8. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
- Author
-
Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J.Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, A., Froelich, S., Gardner, P.A., Gelderblom, H., Gokaslan, Z.L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, R.L., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O.J., Patel, S., Penel, N., Picci, P., Pilotti, S., Radaelli, S., Ricchini, F., Rutkowski, P., Scheipl, S., Sen, C., Tamborini, E., Thornton, K.A., Timmermann, B., Torri, V., Tunn, P.U., Uhl, M., Yamada, Y., Weber, D.C., Vanel, D., Varga, P.P., Vleggeert-Lankamp, C.L.A., Casali, P.G., and Sommer, J.
- Published
- 2017
- Full Text
- View/download PDF
9. CO-01.7 - MYART: A QUALITY ASSURANCE PROGRAM FOR MONITORING THE COMPLEXITY AND DELIVERY ERRORS OF ON-LINE-ADAPTED RADIOTHERAPY TREATMENT PLANS
- Author
-
Dusi, F., Amico, A.G., Caricato, P., Cavinato, S., Ceroni, P., Guida, F., Badr, E.K., Paronetto, C., Sapignoli, S., Zandonà, R., Scaggion, A., Sepulcri, M., Krengli, M., and Paiusco, M.
- Published
- 2023
- Full Text
- View/download PDF
10. The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer
- Author
-
Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, Aristei C; Kaidar-Person O; Boersma L; Leonardi MC; Offersen B; Franco P; Arenas M; Bourgier C; Pfeffer R; Kouloulias V; Bölükbaşı Y; Meattini I; Coles C; Luis AM; Masiello V; Palumbo I; Morganti AG; Perrucci E; Tombolini V; Krengli M; Marazzi F; Trigo L; Borghesi S; Ciabattoni A; Ratoša I; Valentini V; Poortmans P, Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, and Aristei C; Kaidar-Person O; Boersma L; Leonardi MC; Offersen B; Franco P; Arenas M; Bourgier C; Pfeffer R; Kouloulias V; Bölükbaşı Y; Meattini I; Coles C; Luis AM; Masiello V; Palumbo I; Morganti AG; Perrucci E; Tombolini V; Krengli M; Marazzi F; Trigo L; Borghesi S; Ciabattoni A; Ratoša I; Valentini V; Poortmans P
- Abstract
The present white paper, referring to the 4th Assisi Think Tank Meeting on breast cancer, reviews state-of-the-art data, on-going studies and research proposals. < 70% agreement in an online questionnaire identified the following clinical challenges: 1: Nodal RT in patients who have a) 1-2 positive sentinel nodes without ALND (axillary lymph node dissection); b) cN1 disease transformed into ypN0 by primary systemic therapy and c) 1-3 positive nodes after mastectomy and ALND. 2. The optimal combination of RT and immunotherapy (IT), patient selection, IT-RT timing, and RT optimal dose, fractionation and target volume. Most experts agreed that RT- IT combination does not enhance toxicity. 3: Re-irradiation for local relapse converged on the use of partial breast irradiation after second breast conserving surgery. Hyperthermia aroused support but is not widely available. Further studies are required to finetune best practice, especially given the increasing use of re-irradiation.Copyright © 2023. Published by Elsevier B.V.
- Published
- 2023
11. Common European Mitochondrial Haplogroups in the Risk for Radiation-induced Subcutaneous Fibrosis in Breast Cancer Patients
- Author
-
Terrazzino, S., Deantonio, L., Cargnin, S., Donis, L., Pisani, C., Masini, L., Gambaro, G., Canonico, P.L., Genazzani, A.A., and Krengli, M.
- Published
- 2016
- Full Text
- View/download PDF
12. The spine instability neoplastic score (SINS) in the assessment of response to radiotherapy for bone metastases
- Author
-
Gallizia, E., Apicella, G., Cena, T., Di Genesio Pagliuca, M., Deantonio, L., and Krengli, M.
- Published
- 2017
- Full Text
- View/download PDF
13. Stereotactic radiotherapy of oligometastatic disease: a new paradigm for a curative approach
- Author
-
Krengli, M., Aristei, C., Borghesi, S., and Magrini, S. M.
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Published
- 2022
14. 1596P The G8 screening tool as an independent predictor of survival in elderly cancer patients
- Author
-
Mennitto, A., primary, Biello, F., additional, Forti, L.G., additional, Siffredi, G., additional, Mokhtar Mahmoud, A., additional, Invernizzi, F., additional, Maggiora, P.M., additional, Rua, A., additional, Branni, C., additional, Gioffi, E., additional, Martini, V., additional, Gobbato, S., additional, Pisani, C., additional, Ferrara, E., additional, Cappelli, M., additional, Catania, E., additional, Ferrante, D., additional, Gaidano, G., additional, Krengli, M., additional, and Gennari, A., additional
- Published
- 2022
- Full Text
- View/download PDF
15. Mucosal melanoma of the upper aero-digestive tract
- Author
-
Krengli, M., Masini, L., Pia, F., Belkacémi, Yazid, editor, Mirimanoff, René-Olivier, editor, and Ozsahin, Mahmut, editor
- Published
- 2010
- Full Text
- View/download PDF
16. Quality of life in patients treated by adjuvant radiotherapy for endometrial and cervical cancers: correlation with dose–volume parameters
- Author
-
Pisani, C., Deantonio, L., Surico, D., Brambilla, M., Galla, A., Ferrara, E., Masini, L., Gambaro, G., Surico, N., and Krengli, M.
- Published
- 2016
- Full Text
- View/download PDF
17. Concurrent chemo-radiotherapy in elderly patients: tolerance and compliance in a series of 137 patients
- Author
-
Di Genesio Pagliuca, M., Perotti, C., Apicella, G., Galla, A., Guffi, M., Paolini, M., Donis, L., Amisano, V., Torrente, S., Manfredda, I., and Krengli, M.
- Published
- 2016
- Full Text
- View/download PDF
18. OC-0272 External validation of the Hemo-Eosinophils-Inflammation index as a prognosticator in anal cancer
- Author
-
Franco, P., primary, Porreca, A., additional, Di Nicola, M., additional, Mantello, G., additional, Valvo, F., additional, Slim, N., additional, Manfrida, S., additional, Gambacorta, M.A., additional, De Felice, F., additional, Vagge, S., additional, Krengli, M., additional, Palazzari, E., additional, Osti, M.F., additional, Gonelli, A., additional, Catalano, G., additional, Pittoni, P., additional, Lupattelli, M., additional, Niespolo, M.R., additional, Rosetto, M.E., additional, Macchia, G., additional, Durante, O., additional, Munoz, F., additional, D'Angelillo, R.M., additional, Genovesi, D., additional, and Caravatta, L., additional
- Published
- 2022
- Full Text
- View/download PDF
19. PO-1287 FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with multimodal therapy
- Author
-
Ferrara, E., primary, Puta, E., additional, Guaschino, R., additional, Turri, L., additional, Franco, P., additional, Gentilli, S., additional, Sacchetti, G.M., additional, Brambilla, M., additional, and Krengli, M., additional
- Published
- 2022
- Full Text
- View/download PDF
20. PO-1081 BMI and SMI variations in HNSCC patients undergoing radiotherapy and nutritional intervention
- Author
-
Mastroleo, F., primary, Pisani, C., additional, Carabelli, G., additional, Collo, A., additional, Garzaro, M., additional, Riso, S., additional, and Krengli, M., additional
- Published
- 2022
- Full Text
- View/download PDF
21. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients
- Author
-
Bellan, M, Patti, G, Hayden, E, Azzolina, D, Pirisi, M, Acquaviva, A, Aimaretti, G, Aluffi Valletti, P, Angilletta, R, Arioli, R, Avanzi, G, Avino, G, Balbo, P, Baldon, G, Baorda, F, Barbero, E, Baricich, A, Barini, M, Barone-Adesi, F, Battistini, S, Beltrame, M, Bertoli, M, Bertolin, S, Bertolotti, M, Betti, M, Bobbio, F, Boffano, P, Boglione, L, Borre, S, Brucoli, M, Calzaducca, E, Cammarata, E, Cantaluppi, V, Cantello, R, Capponi, A, Carriero, A, Casciaro, F, Castello, L, Ceruti, F, Chichino, G, Chirico, E, Cisari, C, Cittone, M, Colombo, C, Comi, C, Croce, E, Daffara, T, Danna, P, Della Corte, F, De Vecchi, S, Dianzani, U, Di Benedetto, D, Esposto, E, Faggiano, F, Falaschi, Z, Ferrante, D, Ferrero, A, Gagliardi, I, Gaidano, G, Galbiati, A, Gallo, S, Garavelli, P, Gardino, C, Garzaro, M, Gastaldello, M, Gavelli, F, Gennari, A, Giacomini, G, Giacone, I, Giai Via, V, Giolitti, F, Gironi, L, Gramaglia, C, Grisafi, L, Inserra, I, Invernizzi, M, Krengli, M, Labella, E, Landi, I, Landi, R, Leone, I, Lio, V, Lorenzini, L, Maconi, A, Malerba, M, Manfredi, G, Martelli, M, Marzari, L, Marzullo, P, Mennuni, M, Montabone, C, Morosini, U, Mussa, M, Nerici, I, Nuzzo, A, Olivieri, C, Padelli, S, Panella, M, Parisini, A, Pasche, A, Pau, A, Pedrinelli, A, Percivale, I, Re, R, Rigamonti, C, Rizzi, E, Rognoni, A, Roveta, A, Salamina, L, Santagostino, M, Saraceno, M, Savoia, P, Sciarra, M, Schimmenti, A, Scotti, L, Spinoni, E, Smirne, C, Tarantino, V, Tillio, P, Vaschetto, R, Vassia, V, Zagaria, D, Zavattaro, E, Zeppegno, P, Zottarelli, F, Sainaghi, P, Bellan M., Patti G., Hayden E., Azzolina D., Pirisi M., Acquaviva A., Aimaretti G., Aluffi Valletti P., Angilletta R., Arioli R., Avanzi G. C., Avino G., Balbo P. E., Baldon G., Baorda F., Barbero E., Baricich A., Barini M., Barone-Adesi F., Battistini S., Beltrame M., Bertoli M., Bertolin S., Bertolotti M., Betti M., Bobbio F., Boffano P., Boglione L., Borre S., Brucoli M., Calzaducca E., Cammarata E., Cantaluppi V., Cantello R., Capponi A., Carriero A., Casciaro F. G., Castello L. M., Ceruti F., Chichino G., Chirico E., Cisari C., Cittone M. G., Colombo C., Comi C., Croce E., Daffara T., Danna P., Della Corte F., De Vecchi S., Dianzani U., Di Benedetto D., Esposto E., Faggiano F., Falaschi Z., Ferrante D., Ferrero A., Gagliardi I., Gaidano G., Galbiati A., Gallo S., Garavelli P. L., Gardino C. A., Garzaro M., Gastaldello M. L., Gavelli F., Gennari A., Giacomini G. M., Giacone I., Giai Via V., Giolitti F., Gironi L. C., Gramaglia C., Grisafi L., Inserra I., Invernizzi M., Krengli M., Labella E., Landi I. C., Landi R., Leone I., Lio V., Lorenzini L., Maconi A., Malerba M., Manfredi G. F., Martelli M., Marzari L., Marzullo P., Mennuni M., Montabone C., Morosini U., Mussa M., Nerici I., Nuzzo A., Olivieri C., Padelli S. A., Panella M., Parisini A., Pasche A., Pau A., Pedrinelli A. R., Percivale I., Re R., Rigamonti C., Rizzi E., Rognoni A., Roveta A., Salamina L., Santagostino M., Saraceno M., Savoia P., Sciarra M., Schimmenti A., Scotti L., Spinoni E., Smirne C., Tarantino V., Tillio P. A., Vaschetto R., Vassia V., Zagaria D., Zavattaro E., Zeppegno P., Zottarelli F., Sainaghi P. P., Bellan, M, Patti, G, Hayden, E, Azzolina, D, Pirisi, M, Acquaviva, A, Aimaretti, G, Aluffi Valletti, P, Angilletta, R, Arioli, R, Avanzi, G, Avino, G, Balbo, P, Baldon, G, Baorda, F, Barbero, E, Baricich, A, Barini, M, Barone-Adesi, F, Battistini, S, Beltrame, M, Bertoli, M, Bertolin, S, Bertolotti, M, Betti, M, Bobbio, F, Boffano, P, Boglione, L, Borre, S, Brucoli, M, Calzaducca, E, Cammarata, E, Cantaluppi, V, Cantello, R, Capponi, A, Carriero, A, Casciaro, F, Castello, L, Ceruti, F, Chichino, G, Chirico, E, Cisari, C, Cittone, M, Colombo, C, Comi, C, Croce, E, Daffara, T, Danna, P, Della Corte, F, De Vecchi, S, Dianzani, U, Di Benedetto, D, Esposto, E, Faggiano, F, Falaschi, Z, Ferrante, D, Ferrero, A, Gagliardi, I, Gaidano, G, Galbiati, A, Gallo, S, Garavelli, P, Gardino, C, Garzaro, M, Gastaldello, M, Gavelli, F, Gennari, A, Giacomini, G, Giacone, I, Giai Via, V, Giolitti, F, Gironi, L, Gramaglia, C, Grisafi, L, Inserra, I, Invernizzi, M, Krengli, M, Labella, E, Landi, I, Landi, R, Leone, I, Lio, V, Lorenzini, L, Maconi, A, Malerba, M, Manfredi, G, Martelli, M, Marzari, L, Marzullo, P, Mennuni, M, Montabone, C, Morosini, U, Mussa, M, Nerici, I, Nuzzo, A, Olivieri, C, Padelli, S, Panella, M, Parisini, A, Pasche, A, Pau, A, Pedrinelli, A, Percivale, I, Re, R, Rigamonti, C, Rizzi, E, Rognoni, A, Roveta, A, Salamina, L, Santagostino, M, Saraceno, M, Savoia, P, Sciarra, M, Schimmenti, A, Scotti, L, Spinoni, E, Smirne, C, Tarantino, V, Tillio, P, Vaschetto, R, Vassia, V, Zagaria, D, Zavattaro, E, Zeppegno, P, Zottarelli, F, Sainaghi, P, Bellan M., Patti G., Hayden E., Azzolina D., Pirisi M., Acquaviva A., Aimaretti G., Aluffi Valletti P., Angilletta R., Arioli R., Avanzi G. C., Avino G., Balbo P. E., Baldon G., Baorda F., Barbero E., Baricich A., Barini M., Barone-Adesi F., Battistini S., Beltrame M., Bertoli M., Bertolin S., Bertolotti M., Betti M., Bobbio F., Boffano P., Boglione L., Borre S., Brucoli M., Calzaducca E., Cammarata E., Cantaluppi V., Cantello R., Capponi A., Carriero A., Casciaro F. G., Castello L. M., Ceruti F., Chichino G., Chirico E., Cisari C., Cittone M. G., Colombo C., Comi C., Croce E., Daffara T., Danna P., Della Corte F., De Vecchi S., Dianzani U., Di Benedetto D., Esposto E., Faggiano F., Falaschi Z., Ferrante D., Ferrero A., Gagliardi I., Gaidano G., Galbiati A., Gallo S., Garavelli P. L., Gardino C. A., Garzaro M., Gastaldello M. L., Gavelli F., Gennari A., Giacomini G. M., Giacone I., Giai Via V., Giolitti F., Gironi L. C., Gramaglia C., Grisafi L., Inserra I., Invernizzi M., Krengli M., Labella E., Landi I. C., Landi R., Leone I., Lio V., Lorenzini L., Maconi A., Malerba M., Manfredi G. F., Martelli M., Marzari L., Marzullo P., Mennuni M., Montabone C., Morosini U., Mussa M., Nerici I., Nuzzo A., Olivieri C., Padelli S. A., Panella M., Parisini A., Pasche A., Pau A., Pedrinelli A. R., Percivale I., Re R., Rigamonti C., Rizzi E., Rognoni A., Roveta A., Salamina L., Santagostino M., Saraceno M., Savoia P., Sciarra M., Schimmenti A., Scotti L., Spinoni E., Smirne C., Tarantino V., Tillio P. A., Vaschetto R., Vassia V., Zagaria D., Zavattaro E., Zeppegno P., Zottarelli F., and Sainaghi P. P.
- Abstract
Clinical features and natural history of coronavirus disease 2019 (COVID-19) differ widely among different countries and during different phases of the pandemia. Here, we aimed to evaluate the case fatality rate (CFR) and to identify predictors of mortality in a cohort of COVID-19 patients admitted to three hospitals of Northern Italy between March 1 and April 28, 2020. All these patients had a confirmed diagnosis of SARS-CoV-2 infection by molecular methods. During the study period 504/1697 patients died; thus, overall CFR was 29.7%. We looked for predictors of mortality in a subgroup of 486 patients (239 males, 59%; median age 71 years) for whom sufficient clinical data were available at data cut-off. Among the demographic and clinical variables considered, age, a diagnosis of cancer, obesity and current smoking independently predicted mortality. When laboratory data were added to the model in a further subgroup of patients, age, the diagnosis of cancer, and the baseline PaO2/FiO2 ratio were identified as independent predictors of mortality. In conclusion, the CFR of hospitalized patients in Northern Italy during the ascending phase of the COVID-19 pandemic approached 30%. The identification of mortality predictors might contribute to better stratification of individual patient risk.
- Published
- 2020
22. Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting
- Author
-
Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, Aristei C; Bölükbaşı Y; Kaidar-Person O; Pfeffer R; Arenas M; Boersma LJ; Ciabattoni A; Coles CE; Franco P; Krengli M; Leonardi MC; Marazzi F; Masiello V; Meattini I; Montero A; Offersen B; Trigo ML; Bourgier C; Genovesi D; Kouloulias V; Morganti AG; Meduri B; Pasinetti N; Pedretti S; Perrucci E; Rivera S; Tombolini V; Vidali C; Valentini V; Poortmans P, Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, and Aristei C; Bölükbaşı Y; Kaidar-Person O; Pfeffer R; Arenas M; Boersma LJ; Ciabattoni A; Coles CE; Franco P; Krengli M; Leonardi MC; Marazzi F; Masiello V; Meattini I; Montero A; Offersen B; Trigo ML; Bourgier C; Genovesi D; Kouloulias V; Morganti AG; Meduri B; Pasinetti N; Pedretti S; Perrucci E; Rivera S; Tombolini V; Vidali C; Valentini V; Poortmans P
- Abstract
We report on the third Assisi Think Tank Meeting (ATTM) on breast cancer, a brainstorming project which involved European radiation and clinical oncologists who were dedicated to breast cancer research and treatment. Held on February 2020, the ATTM aimed at identifying key clinical questions in current clinical practice and "grey" areas requiring research to improve management and outcomes. Before the meeting, three key topics were selected: 1) managing patients with frailty due to either age and/or multi-morbidity; 2) stereotactic radiation therapy and systemic therapy in the management of oligometastatic disease; 3) contralateral breast tumour prevention in BCRA-mutated patients. Clinical practice in these areas was investigated by means of an online questionnaire. In the lapse period between the survey and the meeting, the working groups reviewed data, on-going studies and the clinical challenges which were then discussed in-depth and subjected to intense brainstorming during the meeting; research protocols were also proposed. Methodology, outcome of discussions, conclusions and study proposals are summarized in the present paper. In conclusion, this report presents an in-depth analysis of the state of the art, grey areas and controversies in breast cancer radiation therapy and discusses how to confront them in the absence of evidence-based data to guide clinical decision-making.Copyright © 2022 Elsevier B.V. All rights reserved.
- Published
- 2022
23. o-6-methylguanine-dna methyltransferase (mgmt)-metilated pineal glioblastoma in young women: report of two cases and literature review
- Author
-
Stecco, A, Cavalieri, S, Masini, L, Krengli, M, Cossandi, C, Boldorini, R, and Carriero, A
- Published
- 2022
24. Interstitial brachytherapy for eyelid carcinoma: Outcome analysis in 60 patients
- Author
-
Krengli, M., Masini, L., Comoli, A.M., Negri, E., Deantonio, L., Filomeno, A., and Gambaro, G.
- Published
- 2014
- Full Text
- View/download PDF
25. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)
- Author
-
Navarria, P, Minniti, G, Clerici, E, Tomatis, S, Pinzi, V, Ciammella, P, Galaverni, M, Amelio, D, Scartoni, D, Scoccianti, S, Krengli, M, Masini, L, Draghini, L, Maranzano, E, Borzillo, V, Muto, P, Ferrarese, F, Fariselli, L, Livi, L, Pasqualetti, F, Fiorentino, A, Alongi, F, di Monale, M, Magrini, S, Scorsetti, M, Navarria P., Minniti G., Clerici E., Tomatis S., Pinzi V., Ciammella P., Galaverni M., Amelio D., Scartoni D., Scoccianti S., Krengli M., Masini L., Draghini L., Maranzano E., Borzillo V., Muto P., Ferrarese F., Fariselli L., Livi L., Pasqualetti F., Fiorentino A., Alongi F., di Monale M. B., Magrini S., Scorsetti M., Navarria, P, Minniti, G, Clerici, E, Tomatis, S, Pinzi, V, Ciammella, P, Galaverni, M, Amelio, D, Scartoni, D, Scoccianti, S, Krengli, M, Masini, L, Draghini, L, Maranzano, E, Borzillo, V, Muto, P, Ferrarese, F, Fariselli, L, Livi, L, Pasqualetti, F, Fiorentino, A, Alongi, F, di Monale, M, Magrini, S, Scorsetti, M, Navarria P., Minniti G., Clerici E., Tomatis S., Pinzi V., Ciammella P., Galaverni M., Amelio D., Scartoni D., Scoccianti S., Krengli M., Masini L., Draghini L., Maranzano E., Borzillo V., Muto P., Ferrarese F., Fariselli L., Livi L., Pasqualetti F., Fiorentino A., Alongi F., di Monale M. B., Magrini S., and Scorsetti M.
- Abstract
Introduction: The prognosis of glioma is dismal, and almost all patients relapsed. At recurrence time, several treatment options are considered, but to date there is no a standard of care. The Neurooncology Study Group of the Italian Association of Radiation Oncology (AIRO) collected clinical data regarding a large series of recurrent glioma patients who underwent re-irradiation (re-RT) in Italy. Methods: Data regarding 300 recurrent glioma patients treated from May 2002 to November 2017, were analyzed. All patients underwent re-RT. Surgical resection, followed by re-RT with concomitant and adjuvant chemotherapy was performed. Clinical outcome was evaluated by neurological examination and brain MRI performed, 1 month after radiation therapy and then every 3 months. Results: Re-irradiation was performed at a median interval time (IT) of 16 months from the first RT. Surgical resection before re-RT was performed in 19% of patients, concomitant temozolomide (TMZ) in 16.3%, and maintenance chemotherapy in 29%. Total doses ranged from 9 Gy to 52.5 Gy, with a median biological effective dose of 43 Gy. The median, 1, 2 year OS were 9.7 months, 41% and 17.7%. Low grade glioma histology (p ≪ 0.01), IT > 12 months (p = 0.001), KPS > 70 (p = 0.004), younger age (p = 0.001), high total doses delivered (p = 0.04), and combined treatment performed (p = 0.0008) were recorded as conditioning survival. Conclusion: our data underline re-RT as a safe and feasible treatment with limited rate of toxicity, and a combined ones as a better option for selected patients. The identification of a BED threshold able to obtain a greater benefit on OS, can help in designing future prospective studies.
- Published
- 2019
26. Long-term outcomes of intraoperative radiation therapy during radical prostatectomy for high-risk prostate cancer
- Author
-
Marchioro, G., primary, Perri, D., additional, Zacchero, M., additional, Poletti, F., additional, Palumbo, C., additional, De Angelis, P., additional, Beldì, D., additional, Terrone, C., additional, Krengli, M., additional, Billia, M., additional, and Volpe, A., additional
- Published
- 2021
- Full Text
- View/download PDF
27. 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19
- Author
-
Patel, M., primary, Felip, E., additional, Sharkey, R., additional, Krengli, M., additional, Chester, J.D., additional, Sita-Lumsden, A., additional, Mukherjee, U., additional, Russell, B., additional, Loizidou, A., additional, Colomba, J., additional, Cruz, C. Andrea, additional, Cabirta, A., additional, Camps, I. Ruiz, additional, Brunet, J., additional, Sureda, A., additional, Patriarca, A., additional, Tondini, C., additional, Pinato, D.J., additional, and Cortellini, A., additional
- Published
- 2021
- Full Text
- View/download PDF
28. OC-0620 A multicenter study on Intensity Modulated Radiotherapy techniques for anal carcinoma (RAINSTORM).
- Author
-
Caravatta, L., primary, Mantello, G., additional, Valvo, F., additional, Pierfrancesco, F., additional, Lucrezia, G., additional, Rosa, C., additional, Slim, N., additional, Pittoni, P., additional, De Felice, F., additional, Gerardi, M.A., additional, Vagge, S., additional, Krengli, M., additional, Palazzari, E., additional, Osti, M.F., additional, Catalano, G., additional, Ivaldi, G.B., additional, Galardi, A., additional, Lupattelli, M., additional, Niespolo, R.M., additional, Guido, A., additional, Macchia, G., additional, Gambacorta, M.A., additional, Di Nicola, M., additional, Donato, V., additional, and Genovesi, D., additional
- Published
- 2021
- Full Text
- View/download PDF
29. PO-0956 Radiotherapy in fragile elderly head and neck cancer patients: a single centre experience
- Author
-
Luciani, I., primary, Pisani, C., additional, Masini, L., additional, Destefanis, V., additional, Berretta, S., additional, Ferrara, E., additional, Loi, G., additional, and Krengli, M., additional
- Published
- 2021
- Full Text
- View/download PDF
30. PO-1252 Chemoradiation for anal cancer: correlation of hematologic toxicity and dose to pelvic bone marrow.
- Author
-
Ferrara, E., primary, Luciani, I., additional, Zannetti, M., additional, Mastroleo, F., additional, Brignoli, A., additional, Mattio, B., additional, Turri, L., additional, Vigna, L., additional, Mones, E., additional, Loi, G., additional, and Krengli, M., additional
- Published
- 2021
- Full Text
- View/download PDF
31. SP-0464 Current status of IMPT versus VMAT in head and neck cancer
- Author
-
Krengli, M., primary, Pisani, C., additional, and Franco, P., additional
- Published
- 2021
- Full Text
- View/download PDF
32. PO-0995 Locally advanced nasopharyngeal carcinoma treated with a mixed beam (photons-protons) radiotherapy.
- Author
-
Turturici, I., primary, Marvaso, G., additional, Alterio, D., additional, D’Ippolito, E., additional, Vischioni, B., additional, Ronchi, S., additional, Bonora, M., additional, Vitolo, V., additional, Mastella, E., additional, Magro, G., additional, Franco, P., additional, Krengli, M., additional, Fossati, P., additional, Ricotti, R., additional, Gandini, S., additional, Comi, S., additional, Camarda, A.M., additional, La Rocca, E., additional, Volpe, S., additional, Tagliabue, M., additional, Verri, E., additional, Orlandi, E., additional, Jereczek-Fossa, B.A., additional, and Orecchia, R., additional
- Published
- 2021
- Full Text
- View/download PDF
33. P094 - Local primary tumor and metastasis treatment in patients with newly diagnosed oligometastatic prostate cancer: a prospective multicenter registry (OLIGOS)
- Author
-
Porreca, A., Lista, G., Di Gianfrancesco, L., Sepulcri, M., Corsi, P., Miglioranza, E., Amodeo, A., De Marchi, D., Vitelli, F.D., and Krengli, M.
- Published
- 2023
- Full Text
- View/download PDF
34. Clinical and technical characteristics of intraoperative radiotherapy: Analysis of the ISIORT-Europe database
- Author
-
Krengli, M., Calvo, F.A., Sedlmayer, F., Sole, C.V., Fastner, G., Alessandro, M., Maluta, S., Corvò, R., Sperk, E., Litoborski, M., Pisani, C., Fillini, C., Fusconi, F., Osti, M.F., Tomio, L., Marsiglia, H., Ciabattoni, A., Polkowski, W., Di Grazia, A., Gava, A., Kuten, A., Iotti, C., Gonzalez, C., Sallabanda, M., Dubois, J.-B., Catalano, G., and Valentini, V.
- Published
- 2013
- Full Text
- View/download PDF
35. Perfusion computed tomography assessments of peri-enhancing brain tissue in high-grade gliomas
- Author
-
Stecco, A., Fabbiano, F., Amatuzzo, P., Cignini, E., Brambilla, M., Masini, L., Krengli, M., and Carriero, A.
- Published
- 2013
- Full Text
- View/download PDF
36. Dysphagia after definitive radiotherapy for head and neck cancer: Correlation of dose–volume parameters of the pharyngeal constrictor muscles
- Author
-
Deantonio, L., Masini, L., Brambilla, M., Pia, F., and Krengli, M.
- Published
- 2013
- Full Text
- View/download PDF
37. Simple parameters from complete blood count predict in-hospital mortality in covid-19
- Author
-
Bellan, M., Azzolina, D., Hayden, E., Gaidano, G., Pirisi, M., Acquaviva, A., Aimaretti, G., Valletti, P. A., Angilletta, R., Arioli, R., Avanzi, G. C., Avino, G., Balbo, P. E., Baldon, G., Baorda, F., Barbero, E., Baricich, A., Barini, M., Barone-Adesi, F., Battistini, S., Beltrame, M., Bertoli, M., Bertolin, S., Bertolotti, M., Betti, M., Bobbio, F., Boffano, P., Boglione, L., Borre, S., Brucoli, M., Calzaducca, E., Cammarata, E., Cantaluppi, V., Cantello, R., Capponi, A., Carriero, A., Casciaro, G. F., Castello, L. M., Ceruti, F., Chichino, G., Chirico, E., Cisari, C., Cittone, M. G., Colombo, C., Comi, C., Croce, E., Daffara, T., Danna, P., Corte, F. D., de Vecchi, S., Dianzani, U., Benedetto, D. D., Esposto, E., Faggiano, F., Falaschi, Z., Ferrante, D., Ferrero, A., Gagliardi, I., Galbiati, A., Gallo, S., Garavelli, P. L., Gardino, C. A., Garzaro, M., Gastaldello, M. L., Gavelli, F., Gennari, A., Giacomini, G. M., Giacone, I., Via, V. G., Giolitti, F., Gironi, L. C., Gramaglia, C., Grisafi, L., Inserra, I., Invernizzi, M., Krengli, M., Labella, E., Landi, I. C., Landi, R., Leone, I., Lio, V., Lorenzini, L., Maconi, A., Malerba, M., Manfredi, G. F., Martelli, M., Marzari, L., Marzullo, P., Mennuni, M., Montabone, C., Morosini, U., Mussa, M., Nerici, I., Nuzzo, A., Olivieri, C., Padelli, S. A., Panella, M., Parisini, A., Pasche, A., Patrucco, F., Patti, G., Pau, A., Pedrinelli, A. R., Percivale, I., Ragazzoni, L., Re, R., Rigamonti, C., Rizzi, E., Rognoni, A., Roveta, A., Salamina, L., Santagostino, M., Saraceno, M., Savoia, P., Sciarra, M., Schimmenti, A., Scotti, L., Spinoni, E., Smirne, C., Tarantino, V., Tillio, P. A., Tonello, S., Vaschetto, R., Vassia, V., Zagaria, D., Zavattaro, E., Zeppegno, P., Zottarelli, F., Sainaghi, P. P., Aiosa, G., Airoldi, A., Barco, A., Bargiacchi, O., Bazzano, S., Berni, P., Bianchi, B., Bianco, S., Biffi, S., Binda, V., Bolgeo, T., Bolla, C., Bonato, V., Bonizzoni, G., Bragantini, A., Brustia, D., Bullara, V., Burlone, M., Brustia, F., Caccia, S., Calareso, A., Cammarota, G., Cancelliere, L., Carbone, R., Cassinari, A., Ceriani, E., Cena, T., Clivati, E., Collimedaglia, L., Colombatto, A., Cornella, C., Costanzo, M., Croce, A., de Benedittis, C., Delorenzi, S., Dionisio, R., Donato, P., Esposito, M., Fangazio, S., Feggi, A., Ferrillo, S., Foci, V., Fra, G. P., Gaggino, C., Gambaro, E., Gattoni, E., Gattoni, L., Giacchero, F., Gianfreda, R., Giubertoni, A., Grecu, L., Grossi, F., Guglielmetti, G., Guido, S., Iannantuoni, G., Ingrao, S., Jona, A., Lazzarich, E., Lissandrin, R., Maduli, E., Magne, F., Mantia, E., Marangon, D., Massara, M., Matino, E., Mauri, M. G., Menegatti, M., Moglia, R., Molinari, R., Morelli, S., Morlino, P., Naldi, P., Nebbiolo, C., Omodeo, P., Palmieri, D., Panero, A., Parodi, M., Pedrazzoli, R., Pelazza, C., Penpa, S., Perucca, R., Pirovano, A., Pittau, S., Pochetti, P., Poletti, F., Polla, B., Prandi, P., Prodam, F., Prosperini, P., Puma, A., Quaglia, M., Raie, A., Rapetti, R., Ravera, S., Re, A., Reale, M., Rossati, A., Rossi, M., Rossi, P., Rostagno, R., Salomoni, G., Sama, M. T., Sarchi, E., Sarcoli, M., Sarda, C., Sguazzotti, I., Soddu, D., Sola, D., Stobbione, P., Todoerti, M., Vallese, G. C., Varrasi, C., Veia, A., Vignazia, G. L., Zanotti, I., Zecca, E., Zichittella, D., Zisa, G., and Zoppis, E.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Medicine (General) ,Multivariate analysis ,Article Subject ,Clinical Decision Rules, COVID-19, Prognosis, Blood Cell Count, Hospital Mortality, Severity of Illness Index ,Clinical Biochemistry ,Asymptomatic ,Severity of Illness Index ,NO ,R5-920 ,Internal medicine ,Clinical Decision Rules ,Severity of illness ,Genetics ,80 and over ,Medicine ,Humans ,Hospital Mortality ,Molecular Biology ,Aged ,Retrospective Studies ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Biochemistry (medical) ,Complete blood count ,COVID-19 ,Retrospective cohort study ,Red blood cell distribution width ,General Medicine ,Odds ratio ,Middle Aged ,Prognosis ,Female ,Italy ,Multivariate Analysis ,Blood Cell Count ,Cohort ,medicine.symptom ,business ,Research Article - Abstract
Introduction. The clinical course of Coronavirus Disease 2019 (COVID-19) is highly heterogenous, ranging from asymptomatic to fatal forms. The identification of clinical and laboratory predictors of poor prognosis may assist clinicians in monitoring strategies and therapeutic decisions. Materials and Methods. In this study, we retrospectively assessed the prognostic value of a simple tool, the complete blood count, on a cohort of 664 patients ( F 260; 39%, median age 70 (56-81) years) hospitalized for COVID-19 in Northern Italy. We collected demographic data along with complete blood cell count; moreover, the outcome of the hospital in-stay was recorded. Results. At data cut-off, 221/664 patients (33.3%) had died and 453/664 (66.7%) had been discharged. Red cell distribution width (RDW) ( χ 2 10.4; p < 0.001 ), neutrophil-to-lymphocyte (NL) ratio ( χ 2 7.6; p = 0.006 ), and platelet count ( χ 2 5.39; p = 0.02 ), along with age ( χ 2 87.6; p < 0.001 ) and gender ( χ 2 17.3; p < 0.001 ), accurately predicted in-hospital mortality. Hemoglobin levels were not associated with mortality. We also identified the best cut-off for mortality prediction: a NL ratio > 4.68 was characterized by an odds ratio for in-hospital mortality OR = 3.40 (2.40-4.82), while the OR for a RDW > 13.7 % was 4.09 (2.87-5.83); a platelet count > 166,000 /μL was, conversely, protective (OR: 0.45 (0.32-0.63)). Conclusion. Our findings arise the opportunity of stratifying COVID-19 severity according to simple lab parameters, which may drive clinical decisions about monitoring and treatment.
- Published
- 2021
38. Radiotherapy with intensity-modulated (Imrt) techniques in the treatment of anal carcinoma (rainstorm): A multicenter study on behalf of airo (Italian association of radiotherapy and clinical oncology) gastrointestinal study group
- Author
-
Caravatta, L., Mantello, G., Valvo, F., Franco, P., Gasparini, L., Rosa, C., Slim, N., Manfrida, S., De Felice, F., Gerardi, M. A., Vagge, S., Krengli, M., Palazzari, E., Osti, M. F., Gonnelli, A., Catalano, G., Pittoni, P., Ivaldi, G. B., Galardi, A., Lupattelli, M., Rosetto, M. E., Niespolo, R. M., Guido, A., Durante, O., Macchia, G., Munoz, F., El Khouzai, B., Lucido, M. R., Porreca, A., Di Nicola, M., Gambacorta, M. A., Donato, V., Genovesi, D., Manfrida S., Macchia G., Porreca A., Gambacorta M. A. (ORCID:0000-0001-5455-8737), Caravatta, L., Mantello, G., Valvo, F., Franco, P., Gasparini, L., Rosa, C., Slim, N., Manfrida, S., De Felice, F., Gerardi, M. A., Vagge, S., Krengli, M., Palazzari, E., Osti, M. F., Gonnelli, A., Catalano, G., Pittoni, P., Ivaldi, G. B., Galardi, A., Lupattelli, M., Rosetto, M. E., Niespolo, R. M., Guido, A., Durante, O., Macchia, G., Munoz, F., El Khouzai, B., Lucido, M. R., Porreca, A., Di Nicola, M., Gambacorta, M. A., Donato, V., Genovesi, D., Manfrida S., Macchia G., Porreca A., and Gambacorta M. A. (ORCID:0000-0001-5455-8737)
- Abstract
A multi-institutional retrospective study was conducted to evaluate the pattern of care and clinical outcomes of anal cancer patients treated with intensity-modulated radiotherapy (IMRT) techniques. In a cohort of 987 patients, the clinical complete response (CR) rate (beyond 6 months) was 90.6%. The 3-year local control (LC) rate was 85.8% (95% CI: 84.4–87.2), and the 3-year colostomy-free survival (CFS) rate was 77.9% (95% CI: 76.1–79.8). Three-year progression-free survival (PFS) and overall survival (OS) rates were 80.2% and 88.1% (95% CI: 78.8–89.4) (95% CI: 78.5–81.9), respectively. Histological grade 3 and nodal involvement were associated with lower CR (p = 0.030 and p = 0.004, respectively). A statistically significant association was found between advanced stage and nodal involvement, and LC, CFS, PFS, OS and event-free survival (EFS). Overall treatment time (OTT) ≥45 days showed a trend for a lower PFS (p = 0.050) and was significantly associated with lower EFS (p = 0.030) and histological grade 3 with a lower LC (p = 0.025). No statistically significant association was found between total dose, dose/fraction and/or boost modality and clinical outcomes. This analysis reports excellent clinical results and a mild toxicity profile, confirming IMRT techniques as standard of care for the curative treatment of anal cancer patients. Lymph node involvement and histological grade have been confirmed as the most important negative prognostic factors.
- Published
- 2021
39. Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
- Author
-
Reverberi, C, Volpe, S, Balestrini, D, Buglione, M, Navarria, P, Scoccianti, S, Panciani, P, Krengli, M, Pirtoli, L, Bordi, L, Pappagallo, G, Angelillo, R, Magrini, S, Arcangeli, S, Pappagallo, GL, Angelillo, RMD, Magrini, SM, Reverberi, C, Volpe, S, Balestrini, D, Buglione, M, Navarria, P, Scoccianti, S, Panciani, P, Krengli, M, Pirtoli, L, Bordi, L, Pappagallo, G, Angelillo, R, Magrini, S, Arcangeli, S, Pappagallo, GL, Angelillo, RMD, and Magrini, SM
- Abstract
Purpose: To perform a systematic review of the current level of evidence on post-operative management following brain metastasectomy (namely: adjuvant stereotactic radiosurgery, whole brain radiotherapy or observation), and to propose a GRADE-based dedicated recommendation to inform Radiation Oncologists’ clinical practice. Methods: A panel of expert Radiation Oncologists from the Italian Association of Radiotherapy and Clinical Oncology had defined the search question per the PICO methodology. Electronic databases were independently screened; the Preferred Reporting Items for Systematic Reviews and Meta-Analyses was adopted. The individual and pooled hazard ratios with 95% confidence intervals (CI), as well as the pooled risk ratio (RR) were calculated using a fixed- or random-effects model. Results: Eight full-texts were retrieved: six retrospective studies and two randomized clinical trials. Outcomes of benefit and damage were analyzed for SRS + observation (PICO A) and SRS + WBRT. SRS allowed for increased rates of local control when compared to both observation and WBRT, while evidence was less conclusive for distant brain control, leptomeningeal disease control and overall survival. In the SRS, the incidence of severe radionecrosis was higher as compared to WBRT, despite neurocognitive deterioration rates were lower. Overall, SRS seems to favorably compare with observation and whole brain RT, despite the level of evidence for the recommendation was low and very low, respectively. Conclusion: Despite low level of evidence, the panel concluded that the risk/benefit ratio probably favors adjuvant SRS as compared to the observation and whole brain RT as adjuvant treatments following brain metastasectomy (5 votes/5 participants, 100% attendance).
- Published
- 2021
40. A treatment planning code for inverse planning and 3D optimization in hadrontherapy
- Author
-
Bourhaleb, F., Marchetto, F., Attili, A., Pittà, G., Cirio, R., Donetti, M., Giordanengo, S., Givehchi, N., Iliescu, S., Krengli, M., La Rosa, A., Massai, D., Pecka, A., Pardo, J., and Peroni, C.
- Published
- 2008
- Full Text
- View/download PDF
41. Surgery of the lateral skull base: A 50-year endeavour
- Author
-
Zanoletti, E., Mazzoni, Alberto, Martini, A., Abbritti, R. V., Albertini, R., Alexandre, E., Baro, V., Bartolini, S., Bernardeschi, D., Bivona, R., Bonali, M., Borghesi, I., Borsetto, D., Bovo, R., Breun, M., Calbucci, F., Carlson, M. L., Caruso, A., Caye-Thomasen, P., Cazzador, D., Champagne, P. -O., Colangeli, R., Conte, G., D'Avella, D., Danesi, G., Deantonio, L., Denaro, L., Berardino, F. D., Draghi, R., Ebner, F. H., Favaretto, N., Ferri, G., Fioravanti, A., Froelich, S., Giannuzzi, A., Girasoli, L., Grossardt, B. R., Guidi, M., Hagen, R., Hanakita, S., Hardy, D. G., Iglesias, V. C., Jefferies, S., Jia, H., Kalamarides, M., Kanaan, I. N., Krengli, M., Landi, A., Lauda, L., Lepera, D., Lieber, S., Lloyd, S. L. K., Lovato, A., Maccarrone, F., Macfarlane, R., Magnan, J., Magnoni, L., Marchioni, D., Marinelli, J. P., Marioni, G., Mastronardi, V., Matthies, C., Moffat, D. A., Munari, S., Nardone, M., Pareschi, R., Pavone, C., Piccirillo, E., Piras, G., Presutti, L., Restivo, G., Reznitsky, M., Roca, E., Russo, A., Sanna, M., Sartori, L., Scheich, M., Shehata-Dieler, W., Soloperto, D., Sorrentino, F., Sterkers, O., Taibah, A., Tatagiba, M., Tealdo, G., Vlad, D., Wu, H., Zanetti, D., Zanoletti E., Mazzoni A., Martini A., Abbritti R.V., Albertini R., Alexandre E., Baro V., Bartolini S., Bernardeschi D., Bivona R., Bonali M., Borghesi I., Borsetto D., Bovo R., Breun M., Calbucci F., Carlson M.L., Caruso A., Caye-Thomasen P., Cazzador D., Champagne P.-O., Colangeli R., Conte G., D'Avella D., Danesi G., Deantonio L., Denaro L., Berardino F.D., Draghi R., Ebner F.H., Favaretto N., Ferri G., Fioravanti A., Froelich S., Giannuzzi A., Girasoli L., Grossardt B.R., Guidi M., Hagen R., Hanakita S., Hardy D.G., Iglesias V.C., Jefferies S., Jia H., Kalamarides M., Kanaan I.N., Krengli M., Landi A., Lauda L., Lepera D., Lieber S., Lloyd S.L.K., Lovato A., Maccarrone F., Macfarlane R., Magnan J., Magnoni L., Marchioni D., Marinelli J.P., Marioni G., Mastronardi V., Matthies C., Moffat D.A., Munari S., Nardone M., Pareschi R., Pavone C., Piccirillo E., Piras G., Presutti L., Restivo G., Reznitsky M., Roca E., Russo A., Sanna M., Sartori L., Scheich M., Shehata-Dieler W., Soloperto D., Sorrentino F., Sterkers O., Taibah A., Tatagiba M., Tealdo G., Vlad D., Wu H., and Zanetti D.
- Subjects
Male ,medicine.medical_treatment ,Schwannoma ,Neurosurgical Procedures ,Cohort Studies ,0302 clinical medicine ,Meningeal Neoplasms ,Medicine ,030223 otorhinolaryngology ,Skull Base ,Benign tumors of the skull base ,Lateral approaches to the skull base ,Malignant tumors of the skull base ,Neuroma, Acoustic ,Middle Aged ,Magnetic Resonance Imaging ,3. Good health ,Chirurgia della base cranio laterale ,General Energy ,medicine.anatomical_structure ,Approcci laterali alla base del cranio ,030220 oncology & carcinogenesis ,Head and neck surgery ,Female ,Neurosurgery ,Meningioma ,Research Article ,Adult ,Chirurgia della base del cranio ,medicine.medical_specialty ,Tumori benigni della base del cranio ,Lateral skull base surgery ,Tumori maligni della base del cranio ,Skull Base Neoplasms ,Skull base surgery ,Aged ,Endoscopy ,Hearing Loss ,Humans ,Mastoid ,Retrospective Studies ,Temporal Bone ,Young Adult ,03 medical and health sciences ,otorhinolaryngologic diseases ,business.industry ,General surgery ,medicine.disease ,Radiation therapy ,Skull ,Otorhinolaryngology ,business ,Jugular foramen - Abstract
Chirurgia della base del cranio laterale: 50 anni di impegno.La base del cranio non è anatomicamente divisa in anteriore e laterale, ma è per semplicità che comunemente si intendono i corridoi chirurgici con direzione antero-laterale, laterale pura e postero laterale come “Approcci chirurgici della base del cranio laterale”. Una relazione con titolo “Cinquant’anni di impegno”, di sforzo o di dedizione, vuole essere il riconoscimento a questa chirurgia che nel corso degli anni ha sviluppato interventi sempre più complessi con una morbidità sempre minore. Il principio della chirurgia della base del cranio laterale si fonda sulla possibilità di “fare spazio”, esporre adeguatamente, rimuovere osso per salvaguardare il cervello, insieme alla possibilità di preservare la funzione e adattare l’approccio chirurgico all’istologia della lesione. Il concetto che l’istologia detta l’entità della resezione chirurgica, bilanciando la morbidità intrinseca di ciascun approccio, è oggetto di trattazione nella prima sezione di questa relazione. Nella seconda sezione sono descritti i principali approcci chirurgici, intesi non come descrizione tecnica di ciascun tempo chirurgico, ma dei principi che sono alla base di ciascun approccio. La terza sezione è dedicata alle questioni aperte, quelle ancora irrisolte, inerenti alcuni tumori ed il loro trattamento. L’argomento del neurinoma sporadico dell’ottavo nervo cranico è trattato riportando l'attuale dibattito sulla osservazione, la chirurgia di preservazione dell’udito, la riabilitazione con l’impianto cocleare, la radioterapia e le ricerche recenti su marcatori tumorali predittivi di crescita. Il paraganglioma del forame giugulare è trattato nel contesto della chirurgia radicale, chirurgia parziale, osservazione e radioterapia. La terapia dei meningiomi della base del cranio analizza il punto di vista specifico dell’otochirurgo e del neurochirurgo. Cordomi e condrosarcomi, tumori del sacco endolinfatico, carcinomi dell’orecchio e colesteatoma della rocca sono le altre lesioni affrontate. Infine, nella quarta sezione è proposto un contributo a libera scelta ad autori di riconosciuta esperienza. Lo scopo di questa relazione è stato quello di fornire un aggiornamento della chirurgia della base del cranio laterale dopo 50 anni di duro lavoro e, o forse soprattutto, di permettere alle tante questioni irrisolte, alle domande che ancora non hanno risposta, di trovare espressione, affinchè il dibattito ed il progresso possano continuare con la condivisione di esperienze. Se al termine della lettura vi saranno più domande che risposte, potremo dirci che l’obiettivo di questa relazione è stato raggiunto.Disregarding the widely used division of skull base into anterior and lateral, since the skull base should be conceived as a single anatomic structure, it was to our convenience to group all those approaches that run from the antero-lateral, pure lateral and postero-lateral side of the skull base as “Surgery of the lateral skull base”. “50 years of endeavour” points to the great effort which has been made over the last decades, when more and more difficult surgeries were performed by reducing morbidity. The principle of lateral skull base surgery, “remove skull base bone to approach the base itself and the adjacent sites of the endo-esocranium”, was then combined with function preservation and with tailoring surgery to the pathology. The concept that histology dictates the extent of resection, balancing the intrinsic morbidity of each approach was the object of the first section of the present report. The main surgical approaches were described in the second section and were conceived not as a step-by-step description of technique, but as the highlighthening of the surgical principles. The third section was centered on open issues related to the tumor and its treatment. The topic of vestibular schwannoma was investigated with the current debate on observation, hearing preservation surgery, hearing rehabilitation, radiotherapy and the recent efforts to detect biological markers able to predict tumor growth. Jugular foramen paragangliomas were treated in the frame of radical or partial surgery, radiotherapy, partial “tailored” surgery and observation. Surgery on meningioma was debated from the point of view of the neurosurgeon and of the otologist. Endolymphatic sac tumors and malignant tumors of the external auditory canal were also treated, as well as chordomas, chondrosarcomas and petrous bone cholesteatomas. Finally, the fourth section focused on free-choice topics which were assigned to aknowledged experts. The aim of this work was attempting to report the state of the art of the lateral skull base surgery after 50 years of hard work and, above all, to raise questions on those issues which still need an answer, as to allow progress in knowledge through sharing of various experiences. At the end of the reading, if more doubts remain rather than certainties, the aim of this work will probably be achieved.
- Published
- 2019
42. Change over time of COVID-19 hospital presentation in Northern Italy
- Author
-
Patti, G., Mennuni, M., Della Corte, F., Spinoni, E., Sainaghi, P. P., COVID-UPO Clinical Team, Azzolina, D, Hayden, E, Rognon, A, Grisafi, L, Colombo, C, Lio, V, Pirisi, M, Vaschetto, R, Aimaretti, G, Krengli, M, Avanzi, Gc, Balbo, Pe, Capponi, A, Castello, Lm, Bellan, M, Malerba, M, Garavelli, Pl, Zeppegno, P, Savoia, P, Chichino, G, Olivieri, C, Re, R, Maconi, A, Comi, C, Roveta, A, Bertolotti, M, Carriero, A, Betti, M, Mussa, M, Borrè, S, Cantaluppi, V, Cantello, R, Bobbio, F, and Gavelli, F.
- Subjects
Change over time ,Male ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,media_common.quotation_subject ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,NO ,Cohort Studies ,Presentation ,Internal Medicine ,medicine ,Humans ,Letter to the Editor ,media_common ,Aged ,Aged, 80 and over ,business.industry ,SARS-CoV-2 ,COVID-19 ,Middle Aged ,medicine.disease ,Respiration, Artificial ,Northern italy ,Hospitalization ,Italy ,Female ,Medical emergency ,business - Published
- 2020
43. ADAPTIVE STRATEGY FOR EXTERNAL BEAM RADIOTHERAPY IN PROSTATE CANCER: MANAGEMENT OF THE GEOMETRICAL UNCERTAINTIES WITH ROBUST OPTIMIZATION
- Author
-
Ferrara, E, Beldì, D, Yin, J, Vigna, L, Loi, G, and Krengli, M
- Subjects
Cancer Research ,Radiation ,Oncology ,image-guided radiotherapy ,Radiology, Nuclear Medicine and imaging ,off-line and on-line corrections ,prostate cancer ,tumor and organ motion - Published
- 2020
44. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy
- Author
-
Alterio, (Alterio, D, 1 ), Daniela), D'Ippolito, (D'Ippolito, E, 2 ), Emma), Vischioni, (Vischioni, B, 2 ), Barbara), Fossati, (Fossati, P, Piero)(, 1, Gandini, 2, (Gandini, S, 3 ), Sara), Bonora, (Bonora, M, 2 ), Maria), Ronchi, (Ronchi, S, 2 ), Sara), Vitolo, (Vitolo, V, 2 ), Viviana), Mastella, (Mastella, E, 2 ), Edoardo), Magro, (Magro, G, 2 ), Giuseppe), Franco, (Franco, P, 4 ), Pierfrancesco), Ricardi, (Ricardi, U, 4 ), Umberto), Krengli, Marco, (Krengli, M, 5 ), Marco), Ivaldi, (Ivaldi, G, 6 ), Giovanni), Ferrari, (Ferrari, A, 1 ), Annamaria), Fanetti, (Fanetti, G, Giuseppi)(, 1, Comi, 7, (Comi, S, 8 ), Stefania), Tagliabue, (Tagliabue, M, 9 ), Marta), Verri, (Verri, E, Elena)( 10, ), Ricotti, (Ricotti, R, 2 ), Rosalinda), Ciardo, (Ciardo, D, 1 ), Delia), Jereczek-Fossa, (Jereczek-Fossa, Ba, Barbara Alicja)(, 1, Valvo, 7, (Valvo, F, 2 ), Francesca), Orecchia, (Orecchia, R, Roberto)(, 11, and Less, 12
- Subjects
Male ,medicine.medical_treatment ,Severity of Illness Index ,030218 nuclear medicine & medical imaging ,0302 clinical medicine ,Antineoplastic Combined Chemotherapy Protocols ,Proton Therapy ,Neoadjuvant therapy ,Nasopharyngeal Carcinoma ,Radiotherapy Dosage ,Chemoradiotherapy ,Hematology ,General Medicine ,Middle Aged ,CHEMOTHERAPY ,CANCER ,Neoadjuvant Therapy ,Progression-Free Survival ,Oncology ,030220 oncology & carcinogenesis ,Disease Progression ,SURVIVAL ,Female ,Radiology ,Adult ,Mucositis ,medicine.medical_specialty ,Adolescent ,Nasopharyngeal neoplasm ,Xerostomia ,Young Adult ,03 medical and health sciences ,INTENSITY-MODULATED RADIOTHERAPY ,2-DIMENSIONAL RADIOTHERAPY ,RADIATION ,HEAD ,ONCOLOGY ,medicine ,Humans ,Dosimetry ,Radiology, Nuclear Medicine and imaging ,Radiation Injuries ,Proton therapy ,Aged ,Neoplasm Staging ,Retrospective Studies ,Cancer staging ,business.industry ,Dose-Response Relationship, Radiation ,Nasopharyngeal Neoplasms ,medicine.disease ,Radiation therapy ,Nasopharyngeal carcinoma ,Radiotherapy, Intensity-Modulated ,business ,Follow-Up Studies - Abstract
Objective: To compare radiation-induced toxicity and dosimetry parameters in patients with locally advanced nasopharyngeal cancer (LANPC) treated with a mixed-beam (MB) approach (IMRT followed by proton therapy boost) with an historic cohort of patients treated with a full course of IMRT-only. Material and methods: Twenty-seven patients with LANPC treated with the MB approach were compared to a similar cohort of 17 patients treated with IMRT-only. The MB approach consisted in a first phase of IMRT up to 54–60 Gy followed by a second phase delivered with a proton therapy boost up to 70–74 Gy (RBE). The total dose for patients treated with IMRT-only was 69.96 Gy. Induction chemotherapy was administrated to 59 and 88% and concurrent chemoradiotherapy to 88 and 100% of the MB and IMRT-only patients, respectively. The worst toxicity occurring during the entire course of treatment (acute toxicity) and early-late toxicity were registered according to the Common Terminology Criteria Adverse Events V4.03. Results: The two cohorts were comparable. Patients treated with MB received a significantly higher median total dose to target volumes (p = .02). Acute grade 3 mucositis was found in 11 and 76% (p = .0002) of patients treated with MB and IMRT-only approach, respectively, while grade 2 xerostomia was found in 7 and 35% (p = .02) of patients treated with MB and IMRT-only, respectively. There was no statistical difference in late toxicity. Local progression-free survival (PFS) and progression-free survival curves were similar between the two cohorts of patients (p = .17 and p = .40, respectively). Local control rate was 96% and 81% for patients treated with MB approach and IMRT-only, respectively. Conclusions: Sequential MB approach for LANPC patients provides a significantly lower acute toxicity profile compared to full course of IMRT. There were no differences in early-late morbidities and disease-related outcomes (censored at two-years) but a longer follow-up is required to achieve conclusive results.
- Published
- 2020
- Full Text
- View/download PDF
45. PO-1174: Results of a multinational clinical audit for prostate cancer radiotherapy: the IROCA project
- Author
-
Lopes de Castro, C., primary, Fundowicz, M., additional, Roselló, A., additional, Jové, J., additional, Deantonio, L., additional, Aguiar, A., additional, Pisani, C., additional, Villà, S., additional, Boladeras, A., additional, Konstanty, E., additional, Kruszyna-Mochalska, M., additional, Milecki, P., additional, Jurado-Bruggeman, D., additional, Lencart, J., additional, Modolell, I., additional, Muñoz-Montplet, C., additional, Aliste, L., additional, Torras, M.G., additional, Puigdemont, M., additional, Carvalho, L., additional, Krengli, M., additional, Guedea, F., additional, and Malicki, J., additional
- Published
- 2020
- Full Text
- View/download PDF
46. PD-0175: TTIRS trial:a retrospective analysis of the association between TT or IT and RS for BM from NSCLC
- Author
-
Olmetto, E., primary, Scoccianti, S., additional, Di Franco, R., additional, Anselmo, P., additional, Beltramo, G., additional, Mantovani, C., additional, Osti, M.F., additional, Pinzi, V., additional, Giaj-Levra, N., additional, Bruni, A., additional, Matteucci, P., additional, Pedretti, S., additional, Giudice, E., additional, Tini, P., additional, Krengli, M., additional, Ciammella, P., additional, Pasqualetti, F., additional, Trignani, M., additional, Merlotti, A., additional, Borzillo, V., additional, Franceschini, D., additional, Maranzano, E., additional, Umberto, R., additional, Pierina, N., additional, and Scotti, V., additional
- Published
- 2020
- Full Text
- View/download PDF
47. PD-0431: Multicentre clinical radiotherapy audit in rectal cancer: results of the IROCA project
- Author
-
Fundowicz, M., primary, Aguiar, A., additional, de Castro, C. Lopes, additional, Torras, M.G., additional, Deantonio, L., additional, Konstanty, E., additional, Mochalska, M. Kruszyna, additional, Macia, M., additional, Canals, E., additional, Caro, M., additional, Pisani, C., additional, Zwierzchowska, D., additional, Molero, J., additional, Eraso, A., additional, Lencart, J., additional, Muñoz-Montplet, C., additional, Carvalho, L., additional, Krengli, M., additional, Malicki, J., additional, and Guedea, F., additional
- Published
- 2020
- Full Text
- View/download PDF
48. Mucosal melanoma of the upper aero-digestive tract
- Author
-
Krengli, M., primary, Masini, L., additional, and Pia, F., additional
- Published
- 2009
- Full Text
- View/download PDF
49. EVALUATION OF CGA IMPACT ON THE QOL OF ELDERLY PATIENTS AFFECTED BY SOLID AND LIQUID MALIGNANCIES, TREATED WITH TARGET DIRECTED AGENTS OR COMPLEX MULTIMODALITY TREATMENTS
- Author
-
Burrafato, G., primary, Bruna, R., additional, Cappelli, M., additional, Azzolina, D., additional, Pisani, C., additional, Ferrara, E., additional, Luciani, I., additional, Adesi, F.Barone, additional, Krengli, M., additional, Catania, E., additional, Gaidano, G., additional, and Gennari, A., additional
- Published
- 2019
- Full Text
- View/download PDF
50. Surgery of the lateral skull base:A 50-year endeavour
- Author
-
Zanoletti, E., Mazzoni, A., Martini, A., Abbritti, R. V., Albertini, R., Alexandre, E., Baro, V., Bartolini, S., Bernardeschi, D., Bivona, R., Bonali, M., Borghesi, I., Borsetto, D., Bovo, R., Breun, M., Calbucci, F., Carlson, M. L., Caruso, A., Cayé-Thomasen, P., Cazzador, D., Champagne, P. O., Colangeli, R., Conte, G., D’Avella, D., Danesi, G., Deantonio, L., Denaro, L., Berardino, F. Di, Draghi, R., Ebner, F. H., Favaretto, N., Ferri, G., Fioravanti, A., Froelich, S., Giannuzzi, A., Girasoli, L., Grossardt, B. R., Guidi, M., Hagen, R., Hanakita, S., Hardy, D. G., Iglesias, V. C., Jefferies, S., Jia, H., Kalamarides, M., Kanaan, I. N., Krengli, M., Landi, A., Lauda, L., Lepera, D., Lieber, S., Lloyd, S. L.K., Lovato, A., Maccarrone, F., Macfarlane, R., Magnan, J., Magnoni, L., Marchioni, D., Marinelli, J. P., Marioni, G., Mastronardi, V., Matthies, C., Moffat, D. A., Munari, S., Nardone, M., Pareschi, R., Pavone, C., Piccirillo, E., Piras, G., Presutti, L., Restivo, G., Reznitsky, M., Roca, E., Russo, A., Sanna, M., Sartori, L., Scheich, M., Shehata-Dieler, W., Soloperto, D., Sorrentino, F., Sterkers, O., Taibah, A., Tatagiba, M., Tealdo, G., Vlad, D., Wu, H., and Zanetti, D.
- Subjects
Benign tumors of the skull base ,Lateral approaches to the skull base ,otorhinolaryngologic diseases ,Lateral skull base surgery ,Malignant tumors of the skull base ,Skull base surgery - Abstract
Disregarding the widely used division of skull base into anterior and lateral, since the skull base should be conceived as a single anatomic structure, it was to our convenience to group all those approaches that run from the antero-lateral, pure lateral and postero-lateral side of the skull base as “Surgery of the lateral skull base”. “50 years of endeavour” points to the great effort which has been made over the last decades, when more and more difficult surgeries were performed by reducing morbidity. The principle of lateral skull base surgery, “remove skull base bone to approach the base itself and the adjacent sites of the endo-esocranium”, was then combined with function preservation and with tailoring surgery to the pathology. The concept that histology dictates the extent of resection, balancing the intrinsic morbidity of each approach was the object of the first section of the present report. The main surgical approaches were described in the second section and were conceived not as a step-by-step description of technique, but as the highlighthening of the surgical principles. The third section was centered on open issues related to the tumor and its treatment. The topic of vestibular schwannoma was investigated with the current debate on observation, hearing preservation surgery, hearing rehabilitation, radiotherapy and the recent efforts to detect biological markers able to predict tumor growth. Jugular foramen paragangliomas were treated in the frame of radical or partial surgery, radiotherapy, partial “tailored” surgery and observation. Surgery on meningioma was debated from the point of view of the neurosurgeon and of the otologist. Endolymphatic sac tumors and malignant tumors of the external auditory canal were also treated, as well as chordomas, chondrosarcomas and petrous bone cholesteatomas. Finally, the fourth section focused on free-choice topics which were assigned to aknowledged experts. The aim of this work was attempting to report the state of the art of the lateral skull base surgery after 50 years of hard work and, above all, to raise questions on those issues which still need an answer, as to allow progress in knowledge through sharing of various experiences. At the end of the reading, if more doubts remain rather than certainties, the aim of this work will probably be achieved.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.